반응식
[F:1][C:2]([F:22])([F:21])[C:3]1[CH:8]=[CH:7][C:6]([C:9]2[CH:10]=[CH:11][C:12]([N:15]3[CH2:20][CH2:19][NH:18][CH2:17][CH2:16]3)=[N:13][CH:14]=2)=[CH:5][CH:4]=1.Br[CH2:24][CH2:25][C:26]#[N:27]>>[F:22][C:2]([F:1])([F:21])[C:3]1[CH:4]=[CH:5][C:6]([C:9]2[CH:10]=[CH:11][C:12]([N:15]3[CH2:20][CH2:19][N:18]([CH2:24][CH2:25][C:26]#[N:27])[CH2:17][CH2:16]3)=[N:13][CH:14]=2)=[CH:7][CH:8]=1참가 물질
3
실험 절차
The title compound was prepared by a similar procedure to that described in Example 55, starting from 4-(5-(4-trifluoromethylphenyl)pyridin-2-yl)piperazine and 3-bromopropionitrile.
출처 및 근거
- ORD 기록
- ord-5d1a49e8409e448394314d8374735c27
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08846677B2
연결된 노트
불러오는 중…